Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000021

Chief Medical Officer sold 1,521 shares at $30.88 ($46,968)

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-08 Sale : show line 1 in the form −1,521 $30.88 $46,968 180,183 I
Open-market sales · 1,521 sh · avg $30.88 · $46,968
Loading xslF345X03/wf-form4_167607072949570.xml…